Akari Therapeutics Announces Key Leadership Appointments

JAZZ Stock  USD 121.44  0.60  0.50%   
Slightly above 69% of Jazz Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Jazz Pharmaceuticals PLC stock suggests that many investors are alarmed at this time. Jazz Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Jazz Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
Samir R. Patel, M.D., appointed as Chief Executive Officer Abizer Gaslightwala appointed to Board of Directors BOSTON and LONDON, Dec. 18, 2024 -- Akari Therapeutics, Plc today announced the appointment of Samir R. Patel, M.D., as Chief Executive Officer, effective December 16, 2024. Dr. Patel has served as interim Chief Executive Officer since May 2024. Additionally, the Company announced it has appointed Abizer Gaslightwala to its Board of Directors, effective D

Read at finance.yahoo.com
Yahoo News
  

Jazz Pharmaceuticals PLC Current Investor Sentiment

Panic Vs Confidence

31

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Jazz Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Jazz Pharmaceuticals PLC.

Jazz Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Jazz Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Jazz Pharmaceuticals PLC Historical Investor Sentiment

Investor biases related to Jazz Pharmaceuticals' public news can be used to forecast risks associated with an investment in Jazz. The trend in average sentiment can be used to explain how an investor holding Jazz can time the market purely based on public headlines and social activities around Jazz Pharmaceuticals PLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Jazz Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Jazz Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Jazz Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Jazz Pharmaceuticals.

Jazz Pharmaceuticals Maximum Pain Price Across March 21st 2025 Option Contracts

Jazz Pharmaceuticals' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Jazz Pharmaceuticals close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Jazz Pharmaceuticals' options.

Jazz Pharmaceuticals Fundamental Analysis

We analyze Jazz Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jazz Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jazz Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Jazz Pharmaceuticals is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Jazz Pharmaceuticals PLC Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jazz Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Jazz Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Jazz Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Jazz Pharmaceuticals Related Equities

RAREUltragenyx   5.08   
0%
100.0%
BPMCBlueprint Medicines   3.35   
0%
65.0%
VRDNViridian Therapeutics   2.83   
0%
55.0%
EXELExelixis   2.40   
0%
47.0%
PCVXVaxcyte   2.40   
0%
47.0%
LQDALiquidia Technologies   2.37   
0%
46.0%
ASNDAscendis Pharma   2.32   
0%
45.0%
ALNYAlnylam Pharmaceuticals   2.27   
0%
44.0%
PTGXProtagonist Therapeutics   2.11   
0%
41.0%
LRMRLarimar Therapeutics   2.02   
0%
39.0%
APLSApellis Pharmaceuticals   1.32   
0%
25.0%
HALOHalozyme Therapeutics   0.31   
0%
6.0%
BMRNBiomarin Pharmaceutical   0.16   
0%
3.0%
INCYIncyte   0.18   
3.0%
0%
UTHRUnited Therapeutics   0.26   
5.0%
0%
ARGXArgenx NV   1.17   
23.0%
0%
DNLIDenali Therapeutics   1.20   
23.0%
0%
LEGNLegend Biotech   1.31   
25.0%
0%
TECHBio Techne   2.97   
58.0%
0%
INBXInhibrx   3.01   
59.0%
0%

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.